0001209191-20-030948.txt : 20200520
0001209191-20-030948.hdr.sgml : 20200520
20200520171440
ACCESSION NUMBER: 0001209191-20-030948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200518
FILED AS OF DATE: 20200520
DATE AS OF CHANGE: 20200520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DILLY STEPHEN GEORGE
CENTRAL INDEX KEY: 0001389147
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 20898974
MAIL ADDRESS:
STREET 1: C/O AVIGEN, INC.
STREET 2: 1301 HARBOR BAY PKWY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-18
0
0001001233
SANGAMO THERAPEUTICS, INC
SGMO
0001389147
DILLY STEPHEN GEORGE
C/O SANGAMO THERAPEAUTICS, INC.
7000 MARINA BLVD
BRISBANE
CA
94005
1
0
0
0
Common Stock
2020-05-18
4
A
0
2500
0.00
A
7500
D
Stock Option (Right to Buy)
10.46
2020-05-18
4
A
0
15000
0.00
A
2030-05-17
Common Stock
15000
15000
D
Represents shares of common stock issuable upon settlement of restricted stock units ("RSUs"). The RSUs will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of the Directors of the Issuer. The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 12-month period measured from the grant date.
/s/ Matthew Colvin, Attorney-in-Fact for Stephen G. Dilly
2020-05-20